Crohn’s & Colitis News
Below you’ll find our most recent press releases, along with other articles written by CCFA. This media content highlights the public research outcomes related to our initiatives, studies, and clinical trials. In addition, you can read our expert commentary related to research articles culled from external media sources. For a complete list of all our news content, please visit the News Archive section.
If you are a member of the media interested in speaking with a CCFA spokesperson, contact us today.
Most Recent News
Today, the Crohn's & Colitis Foundation of America (CCFA) announced the launch of IBD Qorus, a ground-breaking collaboration between patients and their healthcare providers that will lead to enhanced health outcomes and improve the quality of care for inflammatory bowel diseases (IBD) patients.
The Crohn’s & Colitis Foundation of America (CCFA) announced that it is developing an IBD Clinical Trials Community with the goal of educating and supporting IBD patients interested in participating in clinical trials.
The Crohn's & Colitis Foundation of America Takes Action and Raises Awareness of Inflammatory Bowel DiseasesMay 19, 2016
To help educate the public about these chronic autoimmune diseases, the Crohn's & Colitis Foundation of America (CCFA), the leading non-profit, voluntary health organization dedicated to finding cures for IBD, is holding its first-ever day of action, CCFA in Action, today for World IBD Day.
More than 100 Advocates Join With the Crohn's and Colitis Foundation of America to Advance Policies to Help Patients with IBDMay 12, 2016
More than 100 inflammatory bowel disease (IBD) patients and their loved ones from 19 states joined with the Crohn’s & Colitis Foundation of America (CCFA) today to meet with Members of Congress and implore them to help limit the cost of care for IBD patients by passing the Patients’ Access to Treatment Act (HR 1600).
CCFA Partners is an online registry
The Crohn’s & Colitis Foundation of America (CCFA) announced today that it was awarded $2.5 million from the Patient-Centered Outcomes Research Institute (PCORI) to study the effectiveness of the specific carbohydrate diet and Mediterranean-style diet to induce remission in patients with Crohn’s disease.